Buyer profile · Local or regional public body
Medicines Discovery Catapult Limited tenders and contracts
Official name on notices: MEDICINES DISCOVERY CATAPULT LIMITED
- Tenders published
- 6
- About one every 61 days
- Contracts awarded
- 12
- To 12 different suppliers
- Value awarded
- £1m
- 9 contracts, frameworks excluded
- Typical contract
- £70k
- Median value awarded
- Open now
- 0
- 2 contracts end in 90 days
Figures cover in the last 12 months, from notices on Find a Tender and Contracts Finder.
Open tenders
Medicines Discovery Catapult Limited has no tenders open right now.
When it goes to market
Tender notices published each month. Active in 4 of 12 months.
What it buys
Procurements in the last 12 months, by trade.
Who it buys from
Suppliers awarded contracts in the last 12 months, by value awarded (frameworks excluded).
How it buys
How much of its work was open to any supplier.
- Advertised openly (any supplier could bid)35%
- Invited quotes (the buyer chose whom to ask)18%
- Direct award (no competition)47%
Scorecard
How we scoreHow Medicines Discovery Catapult Limited has bought over the last 12 months, compared with similar buyers.
- Time to bid
- 27 days
- Shorter than 76% of other public bodies
- Based on 5 advertised tenders
- Advertised openly
- 35%
- Lower than 68% of other public bodies
- Based on 17 procurements
- Won by small firms
- 67%
- Higher than 63% of other public bodies
- Based on 12 winning suppliers
- Split into lots
- 17%
- Lower than 50% of other public bodies
- Based on 6 advertised tenders
- Direct awards
- 47%
- Higher than 76% of other public bodies
- Based on 17 procurements
- Cancelled
- 17%
- Higher than 89% of other public bodies
- Based on 6 tenders
Compared with other other public bodies
This buyer: 27 days
Show as a table
| Range | Buyers |
|---|---|
| 0–5 days | 1 |
| 5–10 days | 0 |
| 10–15 days | 1 |
| 15–20 days | 7 |
| 20–25 days | 12 |
| 25–30 days | 42 |
| 30–35 days | 56 |
| 35–40 days | 17 |
| 40–45 days | 8 |
| 45–50 days | 1 |
| 50–55 days | 0 |
| 55–60 days | 1 |
| 60+ days | 0 |
This buyer: 35%
Show as a table
| Range | Buyers |
|---|---|
| 0–10% | 36 |
| 10–20% | 34 |
| 20–30% | 25 |
| 30–40% | 14 |
| 40–50% | 18 |
| 50–60% | 23 |
| 60–70% | 28 |
| 70–80% | 17 |
| 80–90% | 29 |
| 90–100% | 96 |
This buyer: 67%
Show as a table
| Range | Buyers |
|---|---|
| 0–10% | 6 |
| 10–20% | 14 |
| 20–30% | 25 |
| 30–40% | 27 |
| 40–50% | 44 |
| 50–60% | 49 |
| 60–70% | 45 |
| 70–80% | 39 |
| 80–90% | 29 |
| 90–100% | 25 |
Each column is a group of other public bodies with similar figures. The coloured column holds Medicines Discovery Catapult Limited.See the full scoreboard
Contracts ending in the next 90 days
Contracts like these are often re-tendered. Knowing early gives you time to prepare.
| Contract | Current supplier | Value | Ends |
|---|---|---|---|
| Xenium Single-cell Spatial Transcriptomics/Proteomics Instrument for Medicines Discovery Catapult | 10x Genomics Incorporated | £344k | 17 Dec 2026 |
| Multiplex Biomarker Discover Equipment | Merck Life Science UK Limited | — | 9 Jan 2027 |